BPG is committed to discovery and dissemination of knowledge
Case Report
Copyright: ©Author(s) 2026.
World J Clin Cases. Apr 6, 2026; 14(10): 118579
Published online Apr 6, 2026. doi: 10.12998/wjcc.v14.i10.118579
Table 1 Treatment protocol
Drug class
Medication
Dosage regimen
Rationale
Mood stabilizerSodium valproate500 mg → 1500 mg/dayPrimary choice for mixed episodes; avoids thyroid interactions
Atypical antipsychoticQuetiapine100 mg → 600 mg/dayGuideline-recommended (CANMAT) for mixed features; favorable metabolic profile vs. Olanzapine
Comorbidity managementFelodipine5 mg/dayBP < 140/90 mmHg


Write to the Help Desk